Pharming Stock Reaps Significant Gains After Landmark FDA Approval
Pharming Group N.V. (PHAR) touched a new 52-week high of $17.81 during intraday trading Friday, thanks to FDA approval of its immune disorder drug Leniolisib..
Source: rttnews.com
Page 27 - Pharming Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Pharming Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Pharming Group Today - Breaking & Trending Today
US FDA approves drug to treat genetic disorder
Joenja is expected to launch in the US in early April and will be available for shipment in mid-April, company says
Source: geo.tv
US FDA approves Pharming's immune disorder drug | WTVB | 1590 AM · 95.5 FM
(Reuters) - The U.S. Food and Drug Administration (FDA) on Friday approved Dutch firm Pharming Group's drug to treat a rare genetic disorder that lead...
Source: wtvbam.com
US FDA approves Pharming's immune disorder drug | WTAQ News Talk | 97.5 FM · 1360 AM
By Mariam Sunny and Khushi Mandowara (Reuters) -The U.S. Food and Drug Administration (FDA) on Friday approved Pharming Group's drug to treat a rare g...
Source: wtaq.com
Pharming Group N.V.: Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS
APDS (activated phosphoinositide 3-kinase delta (PI3Kd) syndrome) is a rare and progressive primary immunodeficiency Joenja® is a targeted treatment of APDS for adult and pediatric patients
Source: finanznachrichten.de